Skip to Main Navigation. Each navigation link will open a list of sub navigation links.

Skip to Main Content

Apply to the University of Wyoming

Global Resource Navigation

Give to UW
Download UW Viewbook
Visit Campus


Wyoming Technology Business Center

GlycoBac LLC



UW Student Christoph Geisler and his mentor UW Molecular Biology Professor Don Jarvis created GlycoBac to commercialize certain aspects of Dr. Jarvis' research, which involves the use of genetically engineered insect cells for manufacturing vaccines, diagnostics or therapeutics for use in human and veterinary medicine.

The UW-owned technology will be used by the Laramie-based company, GlycoBac LLC, to create new genetically engineered insect cell lines optimized for this purpose. Those lines will then be broadly offered throughout the biotechnology community as a new biologics manufacturing platform.

Biologics are a class of protein-based drugs that include vaccines, diagnostic testing reagents, and therapeutics, such as high-value cancer-fighting antibodies and proteins that can be used to treat genetic diseases, including diabetes and anemia.

GlycoBac LLC is also a winner of the 2011 John P. Ellbogen $30K Entrepreneurship Competition.

GlycoBac LLC

Share This Page:

1000 E. University Ave. Laramie, WY 82071
UW Operators (307) 766-1121 | Contact Us | Download Adobe Reader

Twitter Icon Youtube Icon Instagram Icon Vimeo Icon Facebook Icon

Accreditation | Emergency Preparedness | Employment at UW | Gainfull Employment | Privacy Policy | Accessibility Accessibility information icon